program details

Germano Di Sciascio, MD, FACC, FESC
Professor & Chairman of Cardiology
Director, Cardiovascular Services
Campus Biomedico University of Rome
Rome, Italy

1) none

1) none

David J. Moliterno, MD, MPH
Professor of Medicine
Chief, Div. of Cardiovascular Medicine
Medical Director, Gill Heart Institute
University of Kentucky
Lexington, KY

1) Consultant

1) Schering Plough, Boston Scientific

E. Magnus Ohman, MD, FRCPI, FESC, FACC, FSCAI
Professor of Medicine
Director, Program for Advanced Coronary Disease
Duke Clinical Research Institute
Duke University Medical Center
Durham, NC

1) Grant Support

2) Consultant

3) Shareholder

4) Speakers Bureau

1) Berlex, Eli Lilly, Millennium Pharmaceuticals, Schering-Plough, Sanofi-Aventis, Bristol-Myers Squibb

2) Abiomed, Datascope, Inovise, Liposcience, Response Biomedical, The Medicines Company

3) Inovise, Savacor, Medtronic

4) CV Therapeutics, Schering Plough

Eric D. Peterson, MD, MPH,  FAHA, FACC
Associate Professor of Medicine
Duke Clinical Research Institute
Duke University Medical Center
Durham, NC

1) Research

1) Merck, Sanofi Aventis, Schering Plough

Mark A. Turco, MD, FACC, FSCAI
Director, Center for Cardiac & Vascular Research
Washington Adventist Hospital
Takoma Park, MD

1) Research, Speaker Bureau

1) Boston Scientific, Medtronic, St. Jude

Paul Gurbel, MD
Director, Sinai Center for Thrombosis Research
Sinai Hospital of Baltimore
Baltimore, MD

1) Research

2) Investigator

1) Astra Zeneca, Bayer, Haemoscope, Millennium, Schering Plough

2) Boston Scientific, Medtronic

C. Michael Gibson, MS, MD
Associate Professor of Medicine
Beth Israel Deaconess Medical Center
Harvard Medical School
Boston, MA

See attached

See attached